| Coborn's Pharmacy #2008 | |
| 705 County Road 75 Nw, Clearwater, Minnesota 55320 | |
| (800) 459-7065 |
| Name | Coborn's Pharmacy #2008 |
|---|---|
| Organization Name | Coborns Inc |
| Location | 705 County Road 75 Nw, Clearwater, Minnesota 55320 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (800) 459-7065 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Akebia Therapeutics, Inc., a small molecule discovery and development company focused on anemia and vascular disorders, today announced that it has dosed the first subjects in a first-in-man Phase 1 study of AKB-9778, a first-in-class human protein tyrosine phosphatase beta (HPTPβ) inhibitor in development for diabetic macular edema (DME) and diabetic retinopathy (DR).
Since 2006, several published studies have associated the use of some acid suppression medications in hospitalized high-risk babies with infections, necrotizing enterocolitis and increased risk of death. Those medications - histamine-2 receptor antagonists, such as ranitidine (Zantac and others), and proton pump inhibitors, such as esomeprazole (Nexium and others) - were originally approved by the U.S. Food and Drug Administration for use in adults and older children.
Integral Molecular, a leader in membrane protein reagents and services, announces the issuance of a key patent protecting its methodology for generating Lipoparticles, which provide highly-concentrated membrane proteins in their native conformation for antibody and drug discovery applications focused on membrane protein targets such as G protein-coupled receptors (GPCRs), ion channels, and transporters.
A team of physicists, physicians and neuroscientists at the Bernstein Center of the University Freiburg did a step forward towards the ambitious goal of predicting epileptic seizures, as published in the latest issue of the journal "Epilepsia".
In order to examine the link between psychosis and creativity, psychiatrist Szabolcs K-ri of Semmelweis University in Hungary focused his research on neuregulin 1, a gene that normally plays a role in a variety of brain processes, including development and strengthening communication between neurons. However, a variant of this gene (or genotype) is associated with a greater risk of developing mental disorders, such as schizophrenia and bipolar disorder.
› Verified 8 days ago
| NPI Number | 1003989641 |
| Organization Name | COBORNS INC |
| Doing Business As | COBORN'S PHARMACY #2008 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 705 County Road 75 Nw, Clearwater, MN 55320 |
| Phone Number | 320-558-2454 |
News Archive
Akebia Therapeutics, Inc., a small molecule discovery and development company focused on anemia and vascular disorders, today announced that it has dosed the first subjects in a first-in-man Phase 1 study of AKB-9778, a first-in-class human protein tyrosine phosphatase beta (HPTPβ) inhibitor in development for diabetic macular edema (DME) and diabetic retinopathy (DR).
Since 2006, several published studies have associated the use of some acid suppression medications in hospitalized high-risk babies with infections, necrotizing enterocolitis and increased risk of death. Those medications - histamine-2 receptor antagonists, such as ranitidine (Zantac and others), and proton pump inhibitors, such as esomeprazole (Nexium and others) - were originally approved by the U.S. Food and Drug Administration for use in adults and older children.
Integral Molecular, a leader in membrane protein reagents and services, announces the issuance of a key patent protecting its methodology for generating Lipoparticles, which provide highly-concentrated membrane proteins in their native conformation for antibody and drug discovery applications focused on membrane protein targets such as G protein-coupled receptors (GPCRs), ion channels, and transporters.
A team of physicists, physicians and neuroscientists at the Bernstein Center of the University Freiburg did a step forward towards the ambitious goal of predicting epileptic seizures, as published in the latest issue of the journal "Epilepsia".
In order to examine the link between psychosis and creativity, psychiatrist Szabolcs K-ri of Semmelweis University in Hungary focused his research on neuregulin 1, a gene that normally plays a role in a variety of brain processes, including development and strengthening communication between neurons. However, a variant of this gene (or genotype) is associated with a greater risk of developing mental disorders, such as schizophrenia and bipolar disorder.
› Verified 8 days ago
News Archive
Akebia Therapeutics, Inc., a small molecule discovery and development company focused on anemia and vascular disorders, today announced that it has dosed the first subjects in a first-in-man Phase 1 study of AKB-9778, a first-in-class human protein tyrosine phosphatase beta (HPTPβ) inhibitor in development for diabetic macular edema (DME) and diabetic retinopathy (DR).
Since 2006, several published studies have associated the use of some acid suppression medications in hospitalized high-risk babies with infections, necrotizing enterocolitis and increased risk of death. Those medications - histamine-2 receptor antagonists, such as ranitidine (Zantac and others), and proton pump inhibitors, such as esomeprazole (Nexium and others) - were originally approved by the U.S. Food and Drug Administration for use in adults and older children.
Integral Molecular, a leader in membrane protein reagents and services, announces the issuance of a key patent protecting its methodology for generating Lipoparticles, which provide highly-concentrated membrane proteins in their native conformation for antibody and drug discovery applications focused on membrane protein targets such as G protein-coupled receptors (GPCRs), ion channels, and transporters.
A team of physicists, physicians and neuroscientists at the Bernstein Center of the University Freiburg did a step forward towards the ambitious goal of predicting epileptic seizures, as published in the latest issue of the journal "Epilepsia".
In order to examine the link between psychosis and creativity, psychiatrist Szabolcs K-ri of Semmelweis University in Hungary focused his research on neuregulin 1, a gene that normally plays a role in a variety of brain processes, including development and strengthening communication between neurons. However, a variant of this gene (or genotype) is associated with a greater risk of developing mental disorders, such as schizophrenia and bipolar disorder.
› Verified 8 days ago
Coborn's Pharmacy #2008 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 705 County Road 75 Nw, Clearwater, Minnesota 55320 Phone: (800) 459-7065 |